Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macerich Company (The) Common Stock (MAC) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

Macerich Company (The) Common StockTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Macerich Company (The) Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Macerich Company (The) Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

MACORKA
Market Cap
$6.39B$5.18B
Volume
2,684,151490,798
Sector
Real EstateHealth
52-Week High
$26.51$113.08
52-Week Low
$16.20$26.19
Typical Hold Time
0 Days0 Days
Enterprise Value
$11.07B$4.31B
Dividend Yield
3.02%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MAC
100% Buy0% Sell
Avg holding period · 0 Days
ORKA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Macerich Company (The) Common Stock

The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.

Read more on MAC →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →